Association between local treatment modalities and event-free survival, overall survival, and local recurrence in patients with localised Ewing Sarcoma. Report from the Ewing 2008 trial
Jazyk angličtina Země Anglie, Velká Británie Médium print-electronic
Typ dokumentu časopisecké články
PubMed
37595489
DOI
10.1016/j.ejca.2023.113260
PII: S0959-8049(23)00362-3
Knihovny.cz E-zdroje
- Klíčová slova
- Bone tumour, Ewing sarcoma, Local therapy,
- MeSH
- doba přežití bez progrese choroby MeSH
- Ewingův sarkom * terapie MeSH
- indukční chemoterapie MeSH
- kombinovaná terapie MeSH
- lidé MeSH
- radiační onkologie * MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
BACKGROUND: Local treatment is a crucial element in the standard of care for Ewing sarcoma (EWS). While systemic treatment is improved in randomised clinical trials, local treatment modalities are discussed controversially. We analysed the association between local therapy and event-free survival (EFS), overall survival (OS), and local recurrence (LR) in prospectively collected data of patients with localised EWS. PATIENTS AND METHODS: We analysed data from the international Ewing 2008 study registered between 2009 and 2019 in 117 centres. After induction chemotherapy, patients received surgery, radiotherapy, or a combination thereof. We performed Cox regression, conducted propensity score-weighted sensitivity analysis, and performed subgroup analyses. Hazard ratios (HRs) and 95% confidence intervals are reported. RESULTS: We included 863 patients with localised EWS (surgery alone: 331, combination therapy: 358, definitive radiotherapy: 174). In patients treated with combination therapy compared to surgery alone, EFS HR was 0.84 (0.57-1.24; p = 0.38), OS HR was 0.84 (0.57-1.23; p = 0.41), and LR HR was 0.58 (0.26-1.31; p = 0.19). Hazards of any event were increased in patients treated with definitive radiotherapy compared to surgery only, HR 1.53 (1.02-2.31; p = 0.04). Patients with poor responses to chemotherapy benefitted from combination therapy over definitive surgery with an EFS HR 0.49 (0.27-0.89; p = 0.02). Patients with pelvic tumours benefitted from combination therapy over surgery only regarding LR, HR 0.12 (0.02-0.72; p = 0.02). CONCLUSION: Patients with poor responses to chemotherapy benefitted from radiotherapy added to surgery. In the whole group, radiotherapy alone as opposed to surgery alone increased the hazards of any event.
Charles University Motol Children's Hospital 5 Uvalu 84 150 06 Prague 5 Czech Republic
Childhood Cancer Center Queen Silvia Children's Hospital Behandlingsvägen 7 416 50 Gothenburg Sweden
Department of Orthopedics and Trauma Medical University of Graz Auenbruggerpl 2 8036 Graz Austria
German Cancer Consortium Hufelandstrasse 55 45147 Essen Germany
Citace poskytuje Crossref.org